Response Oncology

Response Oncology was a healthcare services company that specialized in providing advanced cancer treatment services through a network of outpatient centers. The company focused on high-dose chemotherapy and peripheral blood stem cell transplantation, primarily for patients with breast cancer and other solid tumors. Founded in 1988, it aimed to move complex cancer treatments from inpatient hospital settings to more cost-effective outpatient environments. The company also provided clinical trial management services to pharmaceutical and biotechnology companies. Following financial challenges, the company filed for bankruptcy in 2001, and its assets were subsequently acquired by US Oncology.